SCHEMBL28024010

SCHEMBL28024010

CN(CC[As](C)C)Cc1cccc(Nc2cc(N)ncn2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP3A4 P08684 1/20 0.39
FGFR3 P22607 1/20 0.39
CYP2C19 P33261 1/20 0.39
CCNT1 O60563 5/20 0.38
CDK9 P50750 5/20 0.38
EGFR P00533 5/20 0.38
CDK1 P06493 2/20 0.37
CCNB1 P14635 2/20 0.37
CCNA2 P20248 2/20 0.37
CDK2 P24941 2/20 0.37
CDK5 Q00535 2/20 0.37
CDK5R1 Q15078 2/20 0.37
MAP4K4 O95819 1/20 0.37
CDK4 P11802 1/20 0.37
CCND1 P24385 1/20 0.37
ABL2 P42684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL374581 0.88 LMNA (0.44) ADORA2ALMNACYP1A2CYP2D6CYP3A4
SCHEMBL374636 0.84 CYP2D6 (0.51) ADORA2ALMNACYP1A2CYP2D6CYP3A4
SCHEMBL374544 0.76 TNNI3K (0.48) ADORA2ALMNACYP1A2CYP2D6CYP3A4
SCHEMBL374166 0.72 EGFR (0.61) LMNACYP1A2CYP2D6CYP3A4CYP2C19
SCHEMBL374274 0.71 TNNI3K (0.53) ADORA2ALMNACYP1A2CYP2D6CYP3A4
SCHEMBL8798667 0.70 EGFR (0.61) LMNAEGFRCDK1CCNB1CCNA2
SCHEMBL374504 0.69 EGFR (0.64) ADORA2ALMNACYP1A2CYP2D6CYP3A4
SCHEMBL25920563 0.68 PRMT6 (0.51) CYP1A2CYP3A4FGFR3CYP2C19CDK5
SCHEMBL27344364 0.68 CYP3A4 (0.45) ADORA2ALMNACYP1A2CYP2D6CYP3A4
SCHEMBL3431925 0.67 CDK1 (0.60) LMNACYP1A2CYP2D6CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103121972-B As the pyrimidine urea derivatives of kinase inhibitor NOVARTIS AG (CH) 2015-07-29 CN disclosed